These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7120724)

  • 21. The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma.
    Takanami I; Takeuchi K; Giga M
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1058-63. PubMed ID: 11385371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype.
    Montoya CJ; Cataño JC; Ramirez Z; Rugeles MT; Wilson SB; Landay AL
    Clin Immunol; 2008 Apr; 127(1):1-6. PubMed ID: 18304877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-12 (IL-12) augments cytolytic activity of natural killer cells toward Mycobacterium tuberculosis-infected human monocytes.
    Denis M
    Cell Immunol; 1994 Jul; 156(2):529-36. PubMed ID: 7913000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment.
    Bozzano F; Costa P; Passalacqua G; Dodi F; Ravera S; Pagano G; Canonica GW; Moretta L; De Maria A
    Int Immunol; 2009 Jul; 21(7):779-91. PubMed ID: 19461127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NK cell activity in pulmonary tuberculosis.
    Yoneda T; Kasai M; Ishibashi J; Nishikawa K; Tokunaga T; Mikami R
    Br J Dis Chest; 1983 Apr; 77(2):185-8. PubMed ID: 6871086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in the activity of natural killer cells in lung diseases and related influencing factors].
    Yin BY
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):276-7. PubMed ID: 8156853
    [No Abstract]   [Full Text] [Related]  

  • 28. [Natural killer cells in the peripheral blood of patients with tuberculosis, pneumonia and cancer of the lungs].
    Savula MM; Slivka IuI
    Probl Tuberk; 1988; (11):47-9. PubMed ID: 3222237
    [No Abstract]   [Full Text] [Related]  

  • 29. Natural killer cells in innate immunity and cancer.
    Becknell B; Caligiuri MA
    J Immunother; 2008 Oct; 31(8):685-92. PubMed ID: 18779751
    [No Abstract]   [Full Text] [Related]  

  • 30. Distal procto-colitis, natural cytotoxicity, and essential fatty acids.
    Almallah YZ; Richardson S; O'Hanrahan T; Mowat NA; Brunt PW; Sinclair TS; Ewen S; Heys SD; Eremin O
    Am J Gastroenterol; 1998 May; 93(5):804-9. PubMed ID: 9625132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis.
    Wong KH; Simon JA
    Am J Obstet Gynecol; 2004 Jan; 190(1):44-9. PubMed ID: 14749633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced natural killer cell activity in multi-drug resistant pulmonary tuberculosis.
    Ratcliffe LT; Mackenzie CR; Lukey PT; Ress SR
    Scand J Immunol Suppl; 1992; 11():167-70. PubMed ID: 1514034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of natural cytotoxicity by alloantibodies: part II--Effect of anti HLA antisera on the natural killer activity of human peripheral blood leukocytes against a human & a murine cell line.
    Saxena RK; Spees EK; Adler WH
    Indian J Exp Biol; 1981 Jul; 19(7):595-7. PubMed ID: 7309145
    [No Abstract]   [Full Text] [Related]  

  • 34. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
    Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cells, antibody-dependent cellular cytotoxicity, and complement synthesis by the xenograft itself play a role in xenograft rejection.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):286-7. PubMed ID: 7879005
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
    Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Natural killer cells in middle-aged and elderly tuberculosis patients].
    Adambekov DA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):18-21. PubMed ID: 7778367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Natural killer cell activity in patients with focal scleroderma].
    Suchkova TN; Cheknev SB
    Vestn Dermatol Venerol; 1986; (10):13-7. PubMed ID: 3811577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.